and says that offering leads that stand a better chance of working in preclinical assays is a minimum. "The most valuable thing that you can sell is a molecule with data, and the more data ...

Assays can be performed routinely in 96- or ... as the new-generation immunoassay technology in drug discovery, preclinical studies and basic research.

In collaboration with the UAB Small Animal Imaging Core facility, the Core can employ a radiographic MCC assay using 99mTc-DTPA or Sulfur Colloid to estimate MCC. This method has been successfully ...

Ace Therapeutics, a preclinical contract research provider dedicated to offering comprehensive one-stop services, released ...

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) announced preclinical findings highlighting the copper-binding potential of its ...

The Functional Assay Core conducts μOCT imaging of freshly harvested trachea with or without further experimental exposures ex vivo. Complementary in vitro, in vivo (animal models), and in-human ...

David Geffen School of Medicine at UCLA Preclinical imaging enables the measurement and assessment of biological processes in vivo utilizing technologies such as bioluminescence, fluorescence and ...

The two partners will use the nVista wearable microscope technology to develop a map of the brain and brain circuit-based preclinical assays that could be used to identify drug candidates for ...

CN Bio, announced the launch of its PhysioMimix ® Bioavailability assay kit: Human 18. Harnessing the capabilities of the PhysioMimix Multi-organ System, the kit enhances lead optimization and ...

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the “Company”, an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is ...